Cannabinoids Protect Astrocytes from Ceramide-induced Apoptosis through the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway*

@article{GomezdelPulgar2002CannabinoidsPA,
  title={Cannabinoids Protect Astrocytes from Ceramide-induced Apoptosis through the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway*},
  author={Teresa Gómez del Pulgar and Mar{\'i}a L. de Ceballos and Manuel Guzm{\'a}n and Guillermo Velasco},
  journal={The Journal of Biological Chemistry},
  year={2002},
  volume={277},
  pages={36527 - 36533}
}
Cannabinoids, the active components of marijuana and their endogenous counterparts, exert many of their actions on the central nervous system by binding to the CB1cannabinoid receptor. Different studies have shown that cannabinoids can protect neural cells from different insults. However, those studies have been performed in neurons, whereas no attention has been focused on glial cells. Here we used the pro-apoptotic lipid ceramide to induce apoptosis in astrocytes, and we studied the… 

Figures from this paper

Ceramide sensitizes astrocytes to oxidative stress: protective role of cannabinoids.

Whereas challenge of glioma cells with cannabinoids induces accumulation of de novo -synthesized ceramide and apoptosis, long-term treatment of astrocytes with these compounds does not stimulate this pathway and also abrogates the sensitizing effects of ceramide accumulation.

Cannabinoid receptors and their role in neuroprotection

Two G protein-coupled receptors for marijuana’s psychoactive component, Δ9-tetrahydrocannabinol and CB1 and CB2 receptors, have been cloned to date and might represent an interesting target to develop neuroprotective agents.

Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions

This review summarizes the main molecular mechanisms and new advances in understanding the antioxidative and neuroprotective effects of cannabinoids, and aims to improve treatment options and efficacy by targeting the endocannabinoid system.

Mechanisms of control of neuron survival by the endocannabinoid system.

Findings support that endocannabinoids constitute a new family of lipid mediators that act as instructive signals in the control of neuron survival and activation of CB(2) cannabinoid receptors on glial cells may also participate in neuroprotection by limiting the extent of neuro inflammation.

Effect of Lipid Rafts on Cb2 Receptor Signaling and 2-Arachidonoyl-Glycerol Metabolism in Human Immune Cells1

It is shown that lipid rafts control CB1R, but not CB2R, and endocannabinoid transport in immune and neuronal cells, and that receptor activation triggers similar [35S]guanosine-5′-O-(3-thiotriphosphate) binding in MCD-treated and control cells, similar adenylate cyclase and MAPK activity, and similar MAPK-dependent protection against apoptosis.

Cannabinoid Receptor Agonist WIN-55,212-2 Protects Differentiated PC12 Cells From Organophosphorus- Induced Apoptosis

It is suggested that WIN-55,212-2 protects PC12 cells cultured under 3D conditions from organophosphorus-induced apoptosis, and this 3D culture system may prove to be a useful tool for investigating the neuroprotective effects of cannabinoids.

Astrocyte apoptosis: implications for neuroprotection

Δ9-Tetrahydrocannabinol-Induced Apoptosis in Jurkat Leukemia T Cells Is Regulated by Translocation of Bad to Mitochondria

Analysis of the effect of THC on the upstream and downstream events that modulate the extracellular signal-regulated kinase (ERK) module of mitogen-activated protein kinase pathways primarily in human Jurkat leukemia T cells suggested that Raf-1/MEK/ERK/RSK-mediated Bad translocation played a critical role in THC-induced apoptosis in Jurkat cells.

Cannabinoids Induce Cancer Cell Proliferation via Tumor Necrosis Factor α-Converting Enzyme (TACE/ADAM17)-Mediated Transactivation of the Epidermal Growth Factor Receptor

It is demonstrated that anandamide, Δ9-tetrahydrocannabinol (THC), HU-210, and Win55,212-2 promote mitogenic kinase signaling in cancer cells and thereby contribute to cancer progression in patients.

Advances in Brief Cannabinoids Induce Cancer Cell Proliferation via Tumor Necrosis Factor-Converting Enzyme ( TACE / ADAM 17 )-Mediated Transactivation of the Epidermal Growth Factor Receptor

It is demonstrated that anandamide, -tetrahydrocannabinol (THC), HU-210, and Win55,212-2 promote mitogenic kinase signaling in cancer cells and thereby contribute to cancer progression in patients.
...

References

SHOWING 1-10 OF 45 REFERENCES

The CB(1) cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan.

Cannabinoids exert most of their effects through the CB(1) receptor. This G protein-coupled receptor signals inhibition of adenylyl cyclase, modulation of ion channels, and stimulation of mitogen-

De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis.

De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis of glioma cells, and pharmacological inhibition of ceramide synthesis de novo prevented the stimulation of extracellular-signal-regulated kinase and the inhibition of protein kinase B triggered by cannabinoids.

Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation

It is shown that intratumoral administration of Δ9-tetrahydrocannabinol and the synthetic cannabinoid agonist WIN-55,212-2 induced a considerable regression of malignant gliomas in Wistar rats and in mice deficient in recombination activating gene 2.

Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1

The results strongly suggest that CB1 is not involved in the cellular antioxidant neuroprotective effects of cannabinoids, and the role of CB1 in neuroprotection is elucidated.

The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt.

It is shown here that Delta(9)-tetrahydrocannabinol (THC), the major active component of marijuana, induces the activation of protein kinase B/Akt (PKB), and data indicate that activation of PKB may be responsible for some of the effects of cannabinoids in cells expressing the CB(1) receptor.

The CB1 Cannabinoid Receptor Is Coupled to the Activation of c-Jun N-Terminal Kinase

It is shown that Δ9-tetrahydrocannabinol (THC), the major active component of marijuana, induces the activation of c-Jun N-terminal kinase (JNK), and data indicate that activation of JNK and p38 mitogen-activated protein kinase may be responsible for some of the cellular responses elicited by the CB1 cannabinoid receptor.

Ceramide Inhibits Protein Kinase B/Akt by Promoting Dephosphorylation of Serine 473*

It is demonstrated that PI 3-kinase-dependent kinase 2-catalyzed phosphorylation of serine 473 is the principal target of a ceramide-activated phosphatase.

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

It is reported that anandamide is produced in and released from cultured brain neurons in a calcium ion-dependent manner when the neurons are stimulated with membrane-depolarizing agents, indicating that multiple biochemical pathways may participate in an andamide formation in brain tissue.

Dual role of Fyn in the regulation of FAK+6,7 by cannabinoids in hippocampus.

The specific functional association of Fyn with FAK+6,7 in a pathway regulated by endocannabinoids, in which Fyn may play roles dependent and independent of its catalytic activity is demonstrated.

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.

Cannabidiol was more protective against glutamate neurotoxicity than either ascorbate or alpha-tocopherol, indicating it to be a potent antioxidant, and data suggest that the naturally occurring, nonpsychotropic cannabinoid, cannABidiol, may be a potentially useful therapeutic agent for the treatment of oxidative neurological disorders such as cerebral ischemia.